Publication | Closed Access
1208P Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)
10
Citations
0
References
2021
Year
Prognostic BiomarkersOverall SurvivalMedicineApollo StudyPathologyCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyFinal Results
No additional data available for this publication yet. Check back later!